Lupus Foundation welcomes addition of NHF subsidy list

Letters to the Editor

Lupus Foundation welcomes addition of NHF subsidy list

Friday, March 22, 2019

Print this page Email A Friend!

Dear Editor,

The Lupus Foundation of Jamaica (LFJ) board and its members welcome yesterday's announcement by Prime Minister Andrew Holness that Lupus is to be included as one of the chronic conditions attracting a subsidy from the National Health Fund (NHF).

LFJ has provided its members with access to pharmacy discounts, support group meetings, and health professionals for over 30 years, in addition to our ongoing efforts to increase public awareness of the disease. We applaud this measure as an act of compassion and an indication of greater awareness of Lupus, its prevalence in Jamaica, and the ongoing expenses incurred by affected persons.

Lupus is a chronic or lifelong illness caused by dysfunction of the immune system, and can be a very expensive disease to treat. LFJ hopes that all drugs used to treat Lupus will be on the NHF subsidy list, including drugs treating kidney disease, such as mycophenylate mofetil.

Jamaica is considered to have a high prevalence of the disease with an estimated affected 6,000 people. Lupus most commonly has its onset among young women, but individuals of any gender or age can be affected.

The Lupus Foundation of Jamaica is a voluntary patient organisation and has been in operation since 1984. It aspires to improve the outcome of Systemic Lupus Erythematosus through a better awareness and a deeper understanding of the disease. One of its major activities is patient support and counselling. The foundation encourages research in areas of diagnosis and treatment of Lupus.

Dr Desiree Tulloch-Reid


Lupus Foundation of Jamaica

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at




1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed:

6. If readers wish to report offensive comments, suggest a correction or share a story then please email:

7. Lastly, read our Terms and Conditions and Privacy Policy

comments powered by Disqus



Today's Cartoon

Click image to view full size editorial cartoon